vaccines Flashcards

1
Q

what are the two types of immunisation?

A

passive
active

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

describe passive immunisation

A

The administration of pre-formed “immunity” from one person or animal to another person

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the limitations of passive immunisation?

A

Only humoral (antibody) mediated
(not work if cell mediated!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the advantages for passive immunisation?

A

Gives immediate protection
Effective in immunocompromised patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the disadvantages for passive immunisation?

A

Short-lived
Possible transfer of pathogens
“Serum sickness” on transfer of animal sera

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

2 examples of passive immunisation

A
  1. Human Normal Immunoglobulin (HNIG)
  2. Convalescing Serum ( SARS CO-V2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the three approaches to making a vaccine?

A
  1. inactivated vaccine
  2. Live attenuated vaccine
  3. Viral vector vaccines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how do non living vaccines work?

A

Non-living vaccines do not cause infection, but the antigens contained in it induce an immune response that protects against infection – by non-self antigen recognition.
Non-living vaccines can also be cell-free toxoids - inactivated toxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

problems and limitations with vaccines

A
  • The organisms must be grown to high titre in vitro (viruses and some bacteria difficult/expensive to grow in the lab)
  • Whole pathogens can cause excessive reactogenicity (i.e., adverse reactions, excessive immunological responses)
  • Immune responses are not always close to the normal response to infection, e.g., no mucosal immunity, no CD8 Tc responses
  • Usually need at least 2 shots
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

examples of bacteria used in vaccines

A

diphtheria -formaldehyde treated toxin - rendered a non-toxic “toxoid
tetanus - texoid as above
pertuissis- whooping cough
cholera- heat killed bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

examples of viruses used in vaccines

A

Polio vaccine (Salk) - inactivated virus-IPV
Influenza vaccine - inactivated virus
Hepatitis A vaccine - inactivated virus
Rabies vaccine - inactivated virus
SARS-Co-V2 (Valneva) - inactivated virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are live attenuated vaccines?

A

The organisms replicate within the host and induce an immune response which is protective against the wild-type organism but does not cause disease.

This is more real-life and provides better protection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

define attenuation

A

Where an organism is cultured in such a way that it does not cause disease when inoculated into humans.

It has lost its pathogenicity but retains its antigenicity – (i.e., shape).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

advantages to live attenuated vaccines

A

Immune response more closely mimics that following real infection because its not fixed – no shape change.

Better immune response so lower doses are required, so the scale of in vitro growth needed is lower.

Route of administration may be more favourable (oral).

Fewer doses may be required to provide protection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

problems and limitations with live attenuated vaccines

A
  • Often impossible to balance attenuation and immunogenicity
  • Reversion to virulence
  • Transmissibility
  • Live vaccines may not be so attenuated in immunocompromised host
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

2 examples of bacterial live attenuated vaccines

A
  • Bacille Calmette-Guérin (BCG) Mycobacterium bovis grown over many passages in vitro. Gives some protection against TB (tuberculosis)
  • Salmonella typhi - temperature sensitive strain given orally.
17
Q

examples of viral live attenuated vaccines

A
  • Poliomyelitis (Sabin) - widely used to bring polio to the brink of eradication
  • Vaccinia virus - used in billions of doses to eradicate smallpox due to cross-reactivity between itself and the variola virus
  • Measles, Mumps and Rubella - 3 given together as MMR
18
Q

give examples of pathogens lacking vaccines

A

HIV, malaria, Schistosomiasis, Leishmania spp, Herpes Simplex Virus, CMV, RSV, Rhinoviruses, Group B streptococci, Meningococcus group B, M. leprae…….

19
Q

why are there so many pathogen lacking vaccines?

A

-Pathogen too difficult to grow
-Killed pathogen not protective (shape change)
-Impossible to obtain attenuated and suitably immunogenic strain
-Too many strains causing disease etc.

20
Q

what are the novel vaccine approaches?

A
  • Recombinant Proteins
  • Synthetic Peptides
  • Live Attenuated Vectors
  • mRNA Vaccines
  • Polysaccharide-Protein Conjugates
21
Q

what are recombinant proteins?

A

Genetically Engineered and produced from bacteria, yeast, insect or mammalian cells

22
Q

advantages of recombinant proteins

A

Avoid the problem of having to grow pathogen in vitro

23
Q

disadvantages of recombinant proteins

A

Major difficulties are finding a protein or proteins that are protective and generate a strong enough immune response

24
Q

examples of recombinant proteins

A

Hepatitis B Surface Antigen
HPV vaccines Cervarix and Gardasil (HPV16 and 18)
SARS-Co-V2 – Novavax (recombinant spike protein produced by moth cells in culture, these are purified, assembled into a synthetic nanoparticle for injection – 14 spike proteins per particle)

25
Q

what are synthetic peptides

A

Peptides synthesized directly using a machine - avoids the need for pathogen growth

26
Q

problems with synthetic peptides

A
  • Identifying protective epitopes
  • Inducing a strong response
  • Inducing a broad response
27
Q

what are live attenuated vectors?

A

-Composed of a safe living attenuated viruses that have inserted genes encoding foreign antigens, which are displayed to the immune system.

28
Q

what are DNA vaccines?

A

a mammalian plasmid containing DNA that encode for the foreign protein ( yellow) of interest is injected directly

29
Q

how are DNA vaccines made?

A

This requires a lipid nanocarrier to get the DNA into a human cell. The DNA goes to the nucleus, gets transcribed and the foreign protein expressed with MHC to stimulate the immune response

30
Q

advantages of DNA vaccines

A

-Avoid the need to grow the pathogen, viral vector
* No live organism involved
* DNA is cheap to produce

31
Q

disadvantage of DNA vaccines

A
  • Problem is often poor immunogenicity
  • None on the market
32
Q

how are mRNA vaccines made?

A

-mRNA of the target foreign protein is synthesized in vitro. It is complexed with lipid nanoparticles that stabalise and protect the mRNA from degradation and allow the mRNA to cross the plasma membrane.

The mRNA is translated in the
cytoplasm and the protein presented
on the surface of the cell with MHC
Stimulating the immune response.

33
Q

advantages of mrna vaccines

A
  • Avoid the need to grow the pathogen, viral vector
  • No live organism involved
  • mRNA is relatively cheap to produce
    -Quick to make new variations of vaccine
34
Q

what are t independent antigens

A

Bacterial capsular polysaccharides cannot be processed and presented on MHC class II

No T cell help
Antibody response of low magnitude
Low affinity
Predominantly IgM
Little or no boosting on secondary exposure

35
Q

recent changes to the vaccination programme

A

The addition of a pneumococcal conjugate vaccine (PCV) at 2, 4 and 13 months of age;

A dose of MenC vaccine at 3 and 4 months;

A booster dose of Hib and MenC vaccine (given as a combined Hib/MenC vaccine) at 12 months of age.

HPV vaccine for teenage girls and boys soon

BCG no longer routinely given to teenagers. Targeted on at risk infants.

36
Q
A